The Middle EAST Precision Oncology Market was valued at USD 1.5 billion in 2024 and is projected to reach USD 4.5 billion by 2034, registering a CAGR of 11.5%. This growth trajectory is underpinned by several factors, including the rising prevalence of cancer, advancements in genomic technologies, and an increasing focus on personalized medicine. The demand for precision oncology solutions is...
Portuguese (Brazil) 
English
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Tiếng Việt